Delta Financial Advisors LLC lowered its holdings in Cigna Corp (NYSE:CI) by 6.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,180 shares of the health services provider’s stock after selling 476 shares during the quarter. Delta Financial Advisors LLC’s holdings in Cigna were worth $1,468,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Metropolitan Life Insurance Co NY grew its position in Cigna by 0.6% in the 3rd quarter. Metropolitan Life Insurance Co NY now owns 62,130 shares of the health services provider’s stock valued at $9,431,000 after purchasing an additional 380 shares during the period. Factory Mutual Insurance Co. boosted its holdings in Cigna by 54.6% during the 4th quarter. Factory Mutual Insurance Co. now owns 141,500 shares of the health services provider’s stock worth $28,935,000 after acquiring an additional 50,000 shares during the last quarter. Cornerstone Advisors Inc. boosted its holdings in Cigna by 6.2% during the 4th quarter. Cornerstone Advisors Inc. now owns 1,343 shares of the health services provider’s stock worth $275,000 after acquiring an additional 78 shares during the last quarter. Moon Capital Management LLC boosted its holdings in Cigna by 1.3% during the 4th quarter. Moon Capital Management LLC now owns 23,068 shares of the health services provider’s stock worth $4,717,000 after acquiring an additional 295 shares during the last quarter. Finally, Cognios Capital LLC purchased a new position in Cigna during the 3rd quarter worth $269,000. 87.48% of the stock is owned by institutional investors and hedge funds.

In related news, EVP Steven B. Miller sold 7,145 shares of the business’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $212.15, for a total value of $1,515,811.75. Following the sale, the executive vice president now directly owns 32,071 shares in the company, valued at approximately $6,803,862.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John Partridge sold 3,300 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $203.70, for a total value of $672,210.00. Following the completion of the sale, the director now owns 29,180 shares in the company, valued at $5,943,966. The disclosure for this sale can be found here. Insiders sold a total of 51,545 shares of company stock worth $10,612,704 over the last 90 days. 0.80% of the stock is currently owned by company insiders.

CI has been the topic of a number of analyst reports. Deutsche Bank lifted their price objective on shares of Cigna from $210.00 to $229.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. Evercore ISI initiated coverage on shares of Cigna in a report on Friday, February 7th. They set a “hold” rating and a $230.00 price objective on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $255.00 price objective (up from $245.00) on shares of Cigna in a report on Thursday, February 6th. UBS Group lifted their price objective on shares of Cigna from $222.00 to $244.00 and gave the stock a “buy” rating in a report on Tuesday, January 28th. Finally, Stephens lifted their price objective on shares of Cigna from $242.00 to $270.00 and gave the stock an “overweight” rating in a report on Thursday, January 2nd. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and sixteen have issued a buy rating to the stock. Cigna currently has an average rating of “Buy” and a consensus target price of $237.05.

NYSE CI opened at $222.16 on Friday. The stock has a market capitalization of $78.54 billion, a price-to-earnings ratio of 16.54, a PEG ratio of 1.00 and a beta of 0.79. Cigna Corp has a one year low of $141.95 and a one year high of $224.64. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.43 and a quick ratio of 0.63. The business’s fifty day moving average is $206.20 and its 200-day moving average is $181.01.

Cigna (NYSE:CI) last released its earnings results on Thursday, February 6th. The health services provider reported $4.31 EPS for the quarter, topping the Zacks’ consensus estimate of $4.20 by $0.11. The company had revenue of $36.54 billion for the quarter, compared to analysts’ expectations of $35.20 billion. Cigna had a return on equity of 14.69% and a net margin of 3.32%. The business’s revenue for the quarter was up 165.7% compared to the same quarter last year. During the same period in the previous year, the business posted $2.46 EPS. Research analysts expect that Cigna Corp will post 18.51 EPS for the current fiscal year.

About Cigna

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Read More: What is a portfolio manager?

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.